600285 Henan Lingrui Pharmaceutical
- 23.99
- +0.14+0.59%
Henan Lingrui Pharmaceutical News
Announcement on the completion of the assessment indicators for the third unlocking period of the Henan Lingrui Pharmaceutical Employee Stock Ownership Plan in 2021.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Ling Rui Pharmaceutical
Legal Opinion on the 2023 Annual General Meeting of Shareholders of Henan Lingrui Pharmaceutical Co., Ltd.
Rules of procedure for the board of directors of Henan Ling Rui Pharmaceutical Co., Ltd.
Report on the performance of the Audit Committee of the Board of Directors of Lingrui Pharmaceutical in 2023
Report of the Audit Committee on the performance of supervisory duties by accounting firms in 2023
Implementation Rules of the Special Committee of the Board of Directors of Henan Ling Rui Pharmaceutical Co., Ltd.
Announcement of Ling Rui Pharmaceutical on reducing registered capital, changing the scope of business, and revising the “Articles of Association”
Announcement of Ling Rui Pharmaceutical on adjusting the authorized amount of cash management of own funds
Notice of Lingrui Pharmaceutical on holding the 2023 Annual General Meeting of Shareholders
Meeting materials for the 2023 Annual General Meeting of Shareholders of Ling Rui Pharmaceutical
Announcement of Ling Rui Pharmaceutical on the resignation of an independent director and the by-election of an independent director
Ling Rui Pharmaceutical's shareholder return plan for the next three years (2024-2026)
Ling Rui Pharmaceutical 2023 Internal Control Evaluation Report
Announcement of Ling Rui Pharmaceutical on authorizing the use of idle own funds for short-term investments
Lingrui Pharmaceutical\'s progress announcement on participating in the subscription of private equity fund shares
Announcement of Lingrui Pharmaceutical on participating in the subscription for private equity fund shares
Announcement of Resolutions of the 2022 Annual General Meeting of Shareholders of Ling Rui Pharmaceutical
Legal opinion of Beijing Jintai (Wuhan) Law Firm on the 2022 Annual General Meeting of Shareholders of Henan Lingrui Pharmaceutical Co., Ltd.
Announcement of Ling Rui Pharmaceutical on the Election of Staff Representatives and Supervisors of the Ninth Board of Supervisors
Analysis
Price Target
No Data
